Le diagnostic se fait par échographie et évaluation des signes vitaux fœtaux.
MortinatalitéÉchographie obstétricale
#2
Quels tests sont utilisés pour confirmer la mortinatalité ?
Des tests comme l'échographie et le monitoring fœtal sont utilisés.
MortinatalitéSurveillance fœtale
#3
Quand peut-on suspecter une mortinatalité ?
La mortinatalité est suspectée en cas d'absence de mouvements fœtaux après 28 semaines.
MortinatalitéMouvements fœtaux
#4
Quels signes cliniques indiquent une mortinatalité ?
L'absence de battements cardiaques fœtaux et de mouvements sont des signes clés.
MortinatalitéBattements cardiaques
#5
Peut-on prédire une mortinatalité ?
Certaines conditions médicales peuvent augmenter le risque, mais la prédiction est complexe.
MortinatalitéFacteurs de risque
Symptômes
5
#1
Quels sont les symptômes d'une mortinatalité ?
Les symptômes incluent l'absence de mouvements fœtaux et des douleurs abdominales.
MortinatalitéSymptômes
#2
Comment se manifeste la mortinatalité ?
Elle se manifeste par l'absence de vie fœtale à l'accouchement.
MortinatalitéAccouchement
#3
Y a-t-il des signes avant-coureurs ?
Des signes comme des saignements ou des douleurs peuvent alerter sur des complications.
MortinatalitéComplications
#4
Les femmes ressentent-elles des symptômes ?
Souvent, les femmes ne ressentent pas de symptômes avant la perte fœtale.
MortinatalitéSymptômes
#5
Les symptômes varient-ils selon le trimestre ?
Les symptômes peuvent varier, mais l'absence de mouvements est un indicateur clé.
MortinatalitéTrimestres de grossesse
Prévention
5
#1
Comment prévenir la mortinatalité ?
Un suivi prénatal régulier et une gestion des facteurs de risque sont essentiels.
MortinatalitéSuivi prénatal
#2
Les vaccinations peuvent-elles aider ?
Oui, certaines vaccinations, comme celle contre la grippe, peuvent réduire les risques.
MortinatalitéVaccination
#3
Quel rôle joue l'alimentation dans la prévention ?
Une alimentation équilibrée et nutritive est cruciale pour la santé fœtale.
MortinatalitéNutrition
#4
Le tabagisme influence-t-il la mortinatalité ?
Oui, le tabagisme augmente le risque de mortinatalité et doit être évité.
MortinatalitéTabagisme
#5
L'exercice est-il bénéfique pendant la grossesse ?
Un exercice modéré peut être bénéfique, mais doit être adapté à chaque femme.
MortinatalitéExercice
Traitements
5
#1
Quel traitement est proposé après une mortinatalité ?
Le traitement inclut un suivi psychologique et des soins médicaux pour la mère.
MortinatalitéSoins postnatals
#2
Y a-t-il des options pour les grossesses futures ?
Des conseils génétiques et un suivi médical étroit sont recommandés pour les grossesses futures.
MortinatalitéConseils génétiques
#3
Comment gérer le deuil après une mortinatalité ?
Un soutien psychologique et des groupes de parole peuvent aider à gérer le deuil.
MortinatalitéSoutien psychologique
#4
Des médicaments sont-ils nécessaires après une mortinatalité ?
Des médicaments peuvent être prescrits pour gérer la douleur ou l'anxiété.
MortinatalitéMédicaments
#5
Quel suivi médical est recommandé après une mortinatalité ?
Un suivi régulier avec un obstétricien est essentiel pour la santé de la mère.
MortinatalitéSuivi médical
Complications
5
#1
Quelles complications peuvent survenir après une mortinatalité ?
Des complications psychologiques et physiques peuvent survenir, nécessitant un suivi.
MortinatalitéComplications
#2
La mortinatalité affecte-t-elle la santé mentale ?
Oui, elle peut entraîner des troubles de l'humeur et du stress post-traumatique.
MortinatalitéSanté mentale
#3
Y a-t-il des risques pour les grossesses futures ?
Les femmes ayant connu une mortinatalité peuvent avoir un risque accru de complications.
MortinatalitéGrossesses futures
#4
Comment gérer les complications physiques ?
Un suivi médical et des traitements appropriés sont nécessaires pour gérer les complications.
MortinatalitéSoins médicaux
#5
Les complications sont-elles fréquentes après une mortinatalité ?
Les complications peuvent survenir, mais un suivi adéquat peut les minimiser.
MortinatalitéSuivi médical
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque ?
Les facteurs incluent l'âge maternel avancé, les maladies chroniques et le tabagisme.
MortinatalitéFacteurs de risque
#2
Le stress peut-il influencer la mortinatalité ?
Oui, un stress élevé peut augmenter le risque de complications pendant la grossesse.
MortinatalitéStress
#3
Les antécédents familiaux jouent-ils un rôle ?
Oui, des antécédents de mortinatalité peuvent augmenter le risque pour les futures grossesses.
MortinatalitéAntécédents familiaux
#4
L'obésité est-elle un facteur de risque ?
Oui, l'obésité maternelle est associée à un risque accru de mortinatalité.
MortinatalitéObésité
#5
Les infections peuvent-elles causer une mortinatalité ?
Certaines infections, comme la rubéole, peuvent augmenter le risque de mortinatalité.
MortinatalitéInfections
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mortinatalité : Questions médicales les plus fréquentes",
"headline": "Mortinatalité : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mortinatalité : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-01",
"dateModified": "2026-02-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mortinatalité"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Issue de la grossesse",
"url": "https://questionsmedicales.fr/mesh/D011256",
"about": {
"@type": "MedicalCondition",
"name": "Issue de la grossesse",
"code": {
"@type": "MedicalCode",
"code": "D011256",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G08.686.784.769.496"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Mortinatalité",
"alternateName": "Stillbirth",
"code": {
"@type": "MedicalCode",
"code": "D050497",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Robert M Silver",
"url": "https://questionsmedicales.fr/author/Robert%20M%20Silver",
"affiliation": {
"@type": "Organization",
"name": "Maternal-Fetal Medicine, University of Utah, 30 North 1900 East, 2A200, Salt Lake City, UT 84132, USA."
}
},
{
"@type": "Person",
"name": "George R Saade",
"url": "https://questionsmedicales.fr/author/George%20R%20Saade",
"affiliation": {
"@type": "Organization",
"name": "From the Institute for Genomic Medicine at Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center (K.E.S., J.G., A.R.-P., M.E., N.L., H.H., G.P., J.H., V.A., R.J.W., D.B.G.), and the Departments of Obstetrics and Gynecology (J.G., R.G., R.J.W.) and Pathology and Cell Biology (C.B., A.T., M.G., J.L., A.V.D., V.A.), Columbia University Medical Center, New York; RTI International, Research Triangle Park (V.T., C.B.P.), and the Department of Biostatistics and Bioinformatics, Duke University, Durham (A.S.A.) - both in North Carolina; the Departments of Obstetrics and Gynecology and Cell Biology, University of Texas Medical Branch, Galveston (G.R.S.); the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville (D.J.D.); the Division of Perinatal and Pediatric Pathology, Women and Infants Hospital, Warren Alpert School of Medicine of Brown University, Providence, RI (H.P.); Rollins School of Public Health, Emory University, Atlanta (C.H.); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Pregnancy and Perinatology Branch, Bethesda, MD (U.M.R.); and the University of Utah and Intermountain Healthcare, Salt Lake City (R.M.S.)."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Donald J Dudley",
"url": "https://questionsmedicales.fr/author/Donald%20J%20Dudley",
"affiliation": {
"@type": "Organization",
"name": "From the Institute for Genomic Medicine at Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center (K.E.S., J.G., A.R.-P., M.E., N.L., H.H., G.P., J.H., V.A., R.J.W., D.B.G.), and the Departments of Obstetrics and Gynecology (J.G., R.G., R.J.W.) and Pathology and Cell Biology (C.B., A.T., M.G., J.L., A.V.D., V.A.), Columbia University Medical Center, New York; RTI International, Research Triangle Park (V.T., C.B.P.), and the Department of Biostatistics and Bioinformatics, Duke University, Durham (A.S.A.) - both in North Carolina; the Departments of Obstetrics and Gynecology and Cell Biology, University of Texas Medical Branch, Galveston (G.R.S.); the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville (D.J.D.); the Division of Perinatal and Pediatric Pathology, Women and Infants Hospital, Warren Alpert School of Medicine of Brown University, Providence, RI (H.P.); Rollins School of Public Health, Emory University, Atlanta (C.H.); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Pregnancy and Perinatology Branch, Bethesda, MD (U.M.R.); and the University of Utah and Intermountain Healthcare, Salt Lake City (R.M.S.)."
}
},
{
"@type": "Person",
"name": "Halit Pinar",
"url": "https://questionsmedicales.fr/author/Halit%20Pinar",
"affiliation": {
"@type": "Organization",
"name": "From the Institute for Genomic Medicine at Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center (K.E.S., J.G., A.R.-P., M.E., N.L., H.H., G.P., J.H., V.A., R.J.W., D.B.G.), and the Departments of Obstetrics and Gynecology (J.G., R.G., R.J.W.) and Pathology and Cell Biology (C.B., A.T., M.G., J.L., A.V.D., V.A.), Columbia University Medical Center, New York; RTI International, Research Triangle Park (V.T., C.B.P.), and the Department of Biostatistics and Bioinformatics, Duke University, Durham (A.S.A.) - both in North Carolina; the Departments of Obstetrics and Gynecology and Cell Biology, University of Texas Medical Branch, Galveston (G.R.S.); the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville (D.J.D.); the Division of Perinatal and Pediatric Pathology, Women and Infants Hospital, Warren Alpert School of Medicine of Brown University, Providence, RI (H.P.); Rollins School of Public Health, Emory University, Atlanta (C.H.); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Pregnancy and Perinatology Branch, Bethesda, MD (U.M.R.); and the University of Utah and Intermountain Healthcare, Salt Lake City (R.M.S.)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The genetic approach to stillbirth: A »systematic review«.",
"datePublished": "2023-05-11",
"url": "https://questionsmedicales.fr/article/37072878",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/pd.6354"
}
},
{
"@type": "ScholarlyArticle",
"name": "Trends in Term Intrapartum Stillbirth in Norway.",
"datePublished": "2023-09-05",
"url": "https://questionsmedicales.fr/article/37755831",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2023.34830"
}
},
{
"@type": "ScholarlyArticle",
"name": "Causes of stillbirths at Kgapane hospital, Limpopo province.",
"datePublished": "2024-04-17",
"url": "https://questionsmedicales.fr/article/38708746",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4102/safp.v66i1.5863"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identifying risk of stillbirth using machine learning.",
"datePublished": "2023-06-12",
"url": "https://questionsmedicales.fr/article/37315754",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajog.2023.06.017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of antepartum fetal surveillance for stillbirth prevention.",
"datePublished": "2024-08-28",
"url": "https://questionsmedicales.fr/article/39198037",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14767058.2024.2397538"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques des appareils urinaire et reproducteur",
"item": "https://questionsmedicales.fr/mesh/D012101"
},
{
"@type": "ListItem",
"position": 3,
"name": "Phénomènes physiologiques de la reproduction",
"item": "https://questionsmedicales.fr/mesh/D055703"
},
{
"@type": "ListItem",
"position": 4,
"name": "Reproduction",
"item": "https://questionsmedicales.fr/mesh/D012098"
},
{
"@type": "ListItem",
"position": 5,
"name": "Grossesse",
"item": "https://questionsmedicales.fr/mesh/D011247"
},
{
"@type": "ListItem",
"position": 6,
"name": "Issue de la grossesse",
"item": "https://questionsmedicales.fr/mesh/D011256"
},
{
"@type": "ListItem",
"position": 7,
"name": "Mortinatalité",
"item": "https://questionsmedicales.fr/mesh/D050497"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mortinatalité - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mortinatalité",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mortinatalité",
"description": "Comment diagnostique-t-on une mortinatalité ?\nQuels tests sont utilisés pour confirmer la mortinatalité ?\nQuand peut-on suspecter une mortinatalité ?\nQuels signes cliniques indiquent une mortinatalité ?\nPeut-on prédire une mortinatalité ?",
"url": "https://questionsmedicales.fr/mesh/D050497#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mortinatalité",
"description": "Quels sont les symptômes d'une mortinatalité ?\nComment se manifeste la mortinatalité ?\nY a-t-il des signes avant-coureurs ?\nLes femmes ressentent-elles des symptômes ?\nLes symptômes varient-ils selon le trimestre ?",
"url": "https://questionsmedicales.fr/mesh/D050497#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mortinatalité",
"description": "Comment prévenir la mortinatalité ?\nLes vaccinations peuvent-elles aider ?\nQuel rôle joue l'alimentation dans la prévention ?\nLe tabagisme influence-t-il la mortinatalité ?\nL'exercice est-il bénéfique pendant la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D050497#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mortinatalité",
"description": "Quel traitement est proposé après une mortinatalité ?\nY a-t-il des options pour les grossesses futures ?\nComment gérer le deuil après une mortinatalité ?\nDes médicaments sont-ils nécessaires après une mortinatalité ?\nQuel suivi médical est recommandé après une mortinatalité ?",
"url": "https://questionsmedicales.fr/mesh/D050497#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mortinatalité",
"description": "Quelles complications peuvent survenir après une mortinatalité ?\nLa mortinatalité affecte-t-elle la santé mentale ?\nY a-t-il des risques pour les grossesses futures ?\nComment gérer les complications physiques ?\nLes complications sont-elles fréquentes après une mortinatalité ?",
"url": "https://questionsmedicales.fr/mesh/D050497#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mortinatalité",
"description": "Quels sont les principaux facteurs de risque ?\nLe stress peut-il influencer la mortinatalité ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'obésité est-elle un facteur de risque ?\nLes infections peuvent-elles causer une mortinatalité ?",
"url": "https://questionsmedicales.fr/mesh/D050497#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une mortinatalité ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par échographie et évaluation des signes vitaux fœtaux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer la mortinatalité ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'échographie et le monitoring fœtal sont utilisés."
}
},
{
"@type": "Question",
"name": "Quand peut-on suspecter une mortinatalité ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La mortinatalité est suspectée en cas d'absence de mouvements fœtaux après 28 semaines."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une mortinatalité ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'absence de battements cardiaques fœtaux et de mouvements sont des signes clés."
}
},
{
"@type": "Question",
"name": "Peut-on prédire une mortinatalité ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines conditions médicales peuvent augmenter le risque, mais la prédiction est complexe."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une mortinatalité ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'absence de mouvements fœtaux et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la mortinatalité ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par l'absence de vie fœtale à l'accouchement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes avant-coureurs ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des saignements ou des douleurs peuvent alerter sur des complications."
}
},
{
"@type": "Question",
"name": "Les femmes ressentent-elles des symptômes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Souvent, les femmes ne ressentent pas de symptômes avant la perte fœtale."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le trimestre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier, mais l'absence de mouvements est un indicateur clé."
}
},
{
"@type": "Question",
"name": "Comment prévenir la mortinatalité ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi prénatal régulier et une gestion des facteurs de risque sont essentiels."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations, comme celle contre la grippe, peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et nutritive est cruciale pour la santé fœtale."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il la mortinatalité ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de mortinatalité et doit être évité."
}
},
{
"@type": "Question",
"name": "L'exercice est-il bénéfique pendant la grossesse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un exercice modéré peut être bénéfique, mais doit être adapté à chaque femme."
}
},
{
"@type": "Question",
"name": "Quel traitement est proposé après une mortinatalité ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut un suivi psychologique et des soins médicaux pour la mère."
}
},
{
"@type": "Question",
"name": "Y a-t-il des options pour les grossesses futures ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des conseils génétiques et un suivi médical étroit sont recommandés pour les grossesses futures."
}
},
{
"@type": "Question",
"name": "Comment gérer le deuil après une mortinatalité ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un soutien psychologique et des groupes de parole peuvent aider à gérer le deuil."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils nécessaires après une mortinatalité ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour gérer la douleur ou l'anxiété."
}
},
{
"@type": "Question",
"name": "Quel suivi médical est recommandé après une mortinatalité ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier avec un obstétricien est essentiel pour la santé de la mère."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une mortinatalité ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications psychologiques et physiques peuvent survenir, nécessitant un suivi."
}
},
{
"@type": "Question",
"name": "La mortinatalité affecte-t-elle la santé mentale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des troubles de l'humeur et du stress post-traumatique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour les grossesses futures ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les femmes ayant connu une mortinatalité peuvent avoir un risque accru de complications."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications physiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical et des traitements appropriés sont nécessaires pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes après une mortinatalité ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent survenir, mais un suivi adéquat peut les minimiser."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge maternel avancé, les maladies chroniques et le tabagisme."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer la mortinatalité ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un stress élevé peut augmenter le risque de complications pendant la grossesse."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de mortinatalité peuvent augmenter le risque pour les futures grossesses."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité maternelle est associée à un risque accru de mortinatalité."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles causer une mortinatalité ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections, comme la rubéole, peuvent augmenter le risque de mortinatalité."
}
}
]
}
]
}
From the Institute for Genomic Medicine at Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center (K.E.S., J.G., A.R.-P., M.E., N.L., H.H., G.P., J.H., V.A., R.J.W., D.B.G.), and the Departments of Obstetrics and Gynecology (J.G., R.G., R.J.W.) and Pathology and Cell Biology (C.B., A.T., M.G., J.L., A.V.D., V.A.), Columbia University Medical Center, New York; RTI International, Research Triangle Park (V.T., C.B.P.), and the Department of Biostatistics and Bioinformatics, Duke University, Durham (A.S.A.) - both in North Carolina; the Departments of Obstetrics and Gynecology and Cell Biology, University of Texas Medical Branch, Galveston (G.R.S.); the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville (D.J.D.); the Division of Perinatal and Pediatric Pathology, Women and Infants Hospital, Warren Alpert School of Medicine of Brown University, Providence, RI (H.P.); Rollins School of Public Health, Emory University, Atlanta (C.H.); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Pregnancy and Perinatology Branch, Bethesda, MD (U.M.R.); and the University of Utah and Intermountain Healthcare, Salt Lake City (R.M.S.).
From the Institute for Genomic Medicine at Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center (K.E.S., J.G., A.R.-P., M.E., N.L., H.H., G.P., J.H., V.A., R.J.W., D.B.G.), and the Departments of Obstetrics and Gynecology (J.G., R.G., R.J.W.) and Pathology and Cell Biology (C.B., A.T., M.G., J.L., A.V.D., V.A.), Columbia University Medical Center, New York; RTI International, Research Triangle Park (V.T., C.B.P.), and the Department of Biostatistics and Bioinformatics, Duke University, Durham (A.S.A.) - both in North Carolina; the Departments of Obstetrics and Gynecology and Cell Biology, University of Texas Medical Branch, Galveston (G.R.S.); the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville (D.J.D.); the Division of Perinatal and Pediatric Pathology, Women and Infants Hospital, Warren Alpert School of Medicine of Brown University, Providence, RI (H.P.); Rollins School of Public Health, Emory University, Atlanta (C.H.); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Pregnancy and Perinatology Branch, Bethesda, MD (U.M.R.); and the University of Utah and Intermountain Healthcare, Salt Lake City (R.M.S.).
From the Institute for Genomic Medicine at Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center (K.E.S., J.G., A.R.-P., M.E., N.L., H.H., G.P., J.H., V.A., R.J.W., D.B.G.), and the Departments of Obstetrics and Gynecology (J.G., R.G., R.J.W.) and Pathology and Cell Biology (C.B., A.T., M.G., J.L., A.V.D., V.A.), Columbia University Medical Center, New York; RTI International, Research Triangle Park (V.T., C.B.P.), and the Department of Biostatistics and Bioinformatics, Duke University, Durham (A.S.A.) - both in North Carolina; the Departments of Obstetrics and Gynecology and Cell Biology, University of Texas Medical Branch, Galveston (G.R.S.); the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville (D.J.D.); the Division of Perinatal and Pediatric Pathology, Women and Infants Hospital, Warren Alpert School of Medicine of Brown University, Providence, RI (H.P.); Rollins School of Public Health, Emory University, Atlanta (C.H.); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Pregnancy and Perinatology Branch, Bethesda, MD (U.M.R.); and the University of Utah and Intermountain Healthcare, Salt Lake City (R.M.S.).
From the Institute for Genomic Medicine at Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center (K.E.S., J.G., A.R.-P., M.E., N.L., H.H., G.P., J.H., V.A., R.J.W., D.B.G.), and the Departments of Obstetrics and Gynecology (J.G., R.G., R.J.W.) and Pathology and Cell Biology (C.B., A.T., M.G., J.L., A.V.D., V.A.), Columbia University Medical Center, New York; RTI International, Research Triangle Park (V.T., C.B.P.), and the Department of Biostatistics and Bioinformatics, Duke University, Durham (A.S.A.) - both in North Carolina; the Departments of Obstetrics and Gynecology and Cell Biology, University of Texas Medical Branch, Galveston (G.R.S.); the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville (D.J.D.); the Division of Perinatal and Pediatric Pathology, Women and Infants Hospital, Warren Alpert School of Medicine of Brown University, Providence, RI (H.P.); Rollins School of Public Health, Emory University, Atlanta (C.H.); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Pregnancy and Perinatology Branch, Bethesda, MD (U.M.R.); and the University of Utah and Intermountain Healthcare, Salt Lake City (R.M.S.).
Maternal-Fetal Medicine, Intermountain Healthcare, University of Utah, 5121 South Cottonwood Street, Suite 100, Murray, UT 84107, USA. Electronic address: jessica.page@hsc.utah.edu.
Centre of Research Excellence in Stillbirth, Mater Research Institute, The University of Queensland, Brisbane, Australia; Sydney Institute of Women, Children and their Families, Sydney Local Health District, NSW Australia; Charles Perkins Centre, University of Sydney, NSW, Australia. Electronic address: adrienne.gordon@sydney.edu.au.
Centre of Research Excellence in Stillbirth, Mater Research Institute, The University of Queensland, Brisbane, Australia; SAHMRI Women and Kids, South Australian Health and Medical Research Institute, Adelaide, Australia.
Griffith University School of Medicine and Gold Coast University Hospital, Gold Coast, Queensland, Australia; Centre of Research Excellence in Stillbirth, Mater Research Institute, The University of Queensland, Brisbane, Australia. Electronic address: d.ellwood@griffith.edu.au.
From Tommy's Maternal and Fetal Health Research Centre, St. Mary's Hospital, Division of Developmental Biology & Medicine, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, United Kingdom (Kerby, Baker, Heazell, Sharps).
The Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, St. Mary's Hospital, Manchester, United Kingdom (Heazell).
From the Institute for Genomic Medicine at Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center (K.E.S., J.G., A.R.-P., M.E., N.L., H.H., G.P., J.H., V.A., R.J.W., D.B.G.), and the Departments of Obstetrics and Gynecology (J.G., R.G., R.J.W.) and Pathology and Cell Biology (C.B., A.T., M.G., J.L., A.V.D., V.A.), Columbia University Medical Center, New York; RTI International, Research Triangle Park (V.T., C.B.P.), and the Department of Biostatistics and Bioinformatics, Duke University, Durham (A.S.A.) - both in North Carolina; the Departments of Obstetrics and Gynecology and Cell Biology, University of Texas Medical Branch, Galveston (G.R.S.); the Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville (D.J.D.); the Division of Perinatal and Pediatric Pathology, Women and Infants Hospital, Warren Alpert School of Medicine of Brown University, Providence, RI (H.P.); Rollins School of Public Health, Emory University, Atlanta (C.H.); Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Pregnancy and Perinatology Branch, Bethesda, MD (U.M.R.); and the University of Utah and Intermountain Healthcare, Salt Lake City (R.M.S.).
Unexplained stillbirth is defined as a stillbirth with no known cause after the exclusion of common causes, including obstetric complications, infections, placental insufficiency or abruption, umbilic...
Fetal death during labor at term is a complication that is rarely studied in high-income countries. There is a need for large population-based studies to examine the rate of term intrapartum stillbirt...
To evaluate trends in term intrapartum stillbirth over time and to investigate the association between the trends and term intrapartum stillbirth risk factors from 1999 to 2018 in Norway....
This cohort study used data from the Medical Birth Registry of Norway from 1999 to 2018 to examine rates of term intrapartum stillbirth and risk factors associated with this event. A population of 1 0...
The main exposure variable was time, which was divided into four 5-year periods: 1999 to 2003, 2004 to 2008, 2009 to 2013, and 2014 to 2018....
The primary study outcome was term intrapartum stillbirth. Risk ratios were calculated, and multivariable logistic regression analyses were conducted to identify factors associated with secular trends...
The study population consisted of 1 021 268 term singleton births (maternal mean [SD] age, 29.72 [5.01] years; mean [SD] gestational age, 39.69 [1.27] weeks). During the study period, there were 95 te...
Findings of this study suggest that, despite increases in maternal and obstetric risk factors, term intrapartum stillbirth rates substantially decreased during the study period. Reasons for this decre...
Stillbirths are a global public health challenge, predominantly affecting low- and middle-income countries. The causes of most stillbirths are preventable....
this study reviewed perinatal clinical audit data from Kgapane Hospital over a 4-year period with a special focus on the factors associated with stillbirths....
File audits were done for all stillbirths occurring at Kgapane Hospital and its catchment area from 2018 to 2021. The data from these audits were analysed to identify factors associated with stillbirt...
A total of 392 stillbirths occurred during the study period at Kgapane Hospital and its surrounding clinics, resulting in a stillborn rate of 19.06/1000 births. Of the 392 stillbirths recorded, audits...
Understanding the causes of stillbirths can guide improvement strategies to reduce this heart-breaking complication of pregnancy.Contribution: Family physicians working in rural hospitals are also res...
Previous predictive models using logistic regression for stillbirth do not leverage the advanced and nuanced techniques involved in sophisticated machine learning methods, such as modeling nonlinear r...
This study aimed to create and refine machine learning models for predicting stillbirth using data available before viability (22-24 weeks) and throughout pregnancy, as well as demographic, medical, a...
This is a secondary analysis of the Stillbirth Collaborative Research Network, which included data from pregnancies resulting in stillborn and live-born infants delivered at 59 hospitals in 5 diverse ...
Among 3000 live births and 982 stillbirths, 101 variables of interest were identified. Of the models incorporating data available before viability, the random forests model had 85.1% accuracy (area un...
Applying advanced machine learning techniques to a comprehensive database of stillbirths and live births with unique and clinically relevant variables resulted in an algorithm that could accurately id...
In 2019 the American College of Obstetricians and Gynecologists (ACOG) issued specific recommendations for performance of antepartum fetal surveillance (AFS) based on individual risk factors. As simil...
Retrospective cohort study of all deliveries between 7/1/2013 and 6/30/2018. Excluded were multiples, anomalous fetuses or newborns, and deliveries before 32 0/7 weeks' gestation. AFS was conducted fr...
16,827 women fulfilled the study inclusion and exclusion criteria, 5711 (34%) had risk factors which prompted AFS; 37% had 2 or more risk factors. SB occurred in 1.8‰ of them (10/5711) (3 had 1 risk f...
Implementation of AFS in women with risk factors similar to those recommended by the ACOG may lower the risk of SB from 32 weeks to that of low-risk pregnancies....
Sub-Saharan African (SSA) countries have high stillbirth rates compared with high-income countries, yet research on risk factors for stillbirth in SSA remain scant....
To identify the modifiable risk factors of stillbirths in SSA and investigate their strength of association using a systematic review....
CINAHL Plus, EMBASE, Global Health and MEDLINE databases were searched for literature....
Observational population- and facility-level studies exploring stillbirth risk factors, published in 2013-2019 were included....
A narrative synthesis of data was undertaken and the potential risk factors were classified into subgroups....
Thirty-seven studies were included, encompassing 20 264 stillbirths. The risk factors were categorised as: maternal antepartum factors (0-4 antenatal care visits, multiple gestations, hypertension, bi...
The overall quality of evidence was low, as many studies were facility based and did not adjust for confounding factors. This review identified preventable risk factors for stillbirth. Focused program...
The trophoblast cells are responsible for the transfer of nutrients between the mother and the foetus and play a major role in placental endocrine function by producing and releasing large amounts of ...
To evaluate the usefulness of data to determine cause of stillbirth in India and Pakistan....
Prospective, observational study....
Study hospitals in India and Pakistan....
200 fetal deaths with placental evaluation and minimally invasive tissue sampling (MITS) of internal organs and polymerase chain reaction (PCR) test for 75 pathogens....
Data defined as useful to determine stillbirth causes....
Placental pathology was the most useful to determine cause of stillbirth. Comparing placental and fetal weight with standard weights was useful in 44.5% and 48.5%, respectively. Lung histology was use...
Based on this analysis, maternal clinical history, placental histology and fetal examination were most informative. Comparing the placental and fetal weights with recognised standards was useful in ne...
Current research aimed at understanding and preventing stillbirth focuses almost exclusively on the role of the placenta. The underlying origins of poor placental function leading to stillbirth, howev...
This is a case-control study of women who have experienced a late miscarriage, spontaneous preterm birth or preterm stillbirth or a pregnancy complicated by placental insufficiency (fetal growth restr...
Ethics approval was obtained from Monash University Human Research Ethics Committee (27900) on 14/07/2021 and will be conducted in accordance with these conditions. Findings from this study will be di...
The Indonesian Healthcare Program starting in 2014 enabled access to healthcare delivery for large population groups. Guidance of usage, infrastructure and healthcare process development were the most...
For univariate group comparison ANOVA method was applied and combined with Scheffé procedure and Bonferoni correction for post-hoc tests. Meanwhile, multivariate approaches through regression analysis...
Specialized hospital facilities (type A/B) for advanced care covered a large part of uncomplicated cases (~35%). Differences between insurance membership groups (poor, non-poor) were not seen. Availab...
Improvement of perinatal outcome should focus on sufficient referral processes, availability of SPOG in provinces dominated by rural/remote demography and avoidance of overtreatment by high C-section ...
